AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award from University of Chicago Booth School of Business

Prestigious recognition for excellent skilled achievement in the development of a successful organization awarded to Booth College of Organization Alumni

Analysis TRIANGLE PARK, N.C., June 3, 2022 /PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), an independently operated subsidiary of Bayer AG, now announced that CEO and Co-Founder Sheila Mikhail was acknowledged by the College of Chicago Booth Faculty of Enterprise for superb expert accomplishment among its alumni. As a 1993 finance MBA graduate with honors, Ms. Mikhail has been recognized with the 2022 Entrepreneurial Award.

“This award is greatly meaningful as the Booth University of Organization is one of the nation’s major ranked organization schools,” mentioned AskBio Co-Founder and CEO Sheila Mikhail. “The award is a reflection of the accomplishments that could not be achievable without the aid of a environment-course workforce at AskBio as we keep on to progress our investigate, clinical candidates and production abilities.”

Ms. Mikhail gained a JD with honors from Northwestern College, a finance MBA with honors from the University of Chicago, and a BS with highest honors from the University of Illinois at Urbana-Champaign. She co-founded AskBio in 2001 with Dr. R. Jude Samulski, who is considered a person of the leading pioneers for AAV gene remedy technology.  Considering the fact that co-founding AskBio, and less than the management of Ms. Mikhail, the enterprise, including its producing amenities, has developed to utilize more than 700 biotech experts running in five international locations.

Eighteen months soon after closing a collection A funding spherical of $235 million in April 2019, Ms. Mikhail orchestrated a $4 billion acquisition by Bayer AG in October 2020.  Under Ms. Mikhail’s management, AskBio is flourishing with an expansive gene treatment technologies toolbox, 3 condition-of-the-artwork manufacturing facilities in San Sebastian Spain and a sturdy therapeutic pipeline, all at several scientific stages, to address Pompe Illness, Limbe Girdle Muscular Dystrophy, Many Procedure Atrophy, Congestive Heart Failure, Huntington’s Sickness, and Parkinson’s Disorder.

“In my see, Sheila is a person of the most achieved Biotech executives in the field,” commented Dr. Samulski, AskBio’s Co-Founder and Chief Scientific Officer. “The recognition by University of Chicago Booth University of Business is a testament of her unparalleled small business acumen merged with her major command of genetic science”

The Distinguished Alumni awards are only obtainable to graduates of Chicago Booth. The Entrepreneurial Award is provided to a person who has demonstrated qualified achievement of the greatest caliber in the administration and development of a successful business and is recognition by colleagues and peers for remarkable leadership and administrative capabilities.

About AskBio

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG obtained in 2020, is a fully built-in gene remedy business focused to developing life-saving medications that get rid of genetic diseases. The enterprise maintains a portfolio of clinical programs throughout a array of neuromuscular, central anxious method, cardiovascular and metabolic disorder indications with a scientific-phase pipeline that involves therapeutics for Pompe ailment, Parkinson’s illness, and congestive coronary heart failure. AskBio’s gene remedy platform involves Pro10™, an marketplace-major proprietary cell line production course of action, and an extensive capsid and promoter library. With worldwide headquarters in Exploration Triangle Park, North Carolina, and European headquarters in Edinburgh, United kingdom, the corporation has generated hundreds of proprietary capsids and promoters, several of which have entered medical tests. Established in 2001 and an early innovator in the gene treatment subject, the business holds extra than 750 patents in areas such as AAV generation and chimeric and self-complementary capsids. Understand extra at www.askbio.com or comply with us on LinkedIn. 

About Bayer

Bayer is a world business with core competencies in the lifestyle science fields of well being care and nourishment. Its products and solutions and products and services are developed to enable persons and the earth prosper by supporting efforts to master the important issues offered by a growing and ageing world population. Bayer is fully commited to driving sustainable development and generating a good effects with its companies. At the exact time, the Team aims to enhance its earning electricity and generate worth via innovation and development. The Bayer model stands for have confidence in, trustworthiness, and high quality throughout the entire world. In fiscal 2021, the Team utilized all over 100,000 people today and had revenue of 44.1 billion euros. R&D costs prior to special merchandise amounted to 5.3 billion euros. For additional information and facts, visit www.bayer.com. 

AskBio Ahead-Searching Statements

This push release is made up of “ahead-wanting statements.” Any statements contained in this press release that are not statements of historical truth could be deemed to be ahead-wanting statements. Text this sort of as “thinks,” “anticipates,” “plans,” “expects,” “will,” “intends,” “possible,” “achievable” and related expressions are meant to establish forward-wanting statements. These ahead-on the lookout statements involve with no limitation statements relating to AskBio’s pipeline of advancement candidates, producing engineering and approach. These forward-seeking statements include hazards and uncertainties, many of which are over and above AskBio’s control. Recognised risks consist of, amid other people: AskBio may perhaps not be ready to execute on its company plans and objectives, including meeting its envisioned or planned regulatory milestones and timelines, its reliance on third-functions, clinical improvement ideas, manufacturing procedures and ideas, and bringing its product candidates to current market, due to a wide variety of reasons, which includes the ongoing COVID-19 pandemic, attainable restrictions of corporation economical and other resources, manufacturing restrictions that may possibly not be expected or solved in a timely fashion, prospective disagreements or other difficulties with our 3rd-occasion collaborators and partners, and regulatory, court or company feedback or conclusions, this kind of as opinions and selections from the United States Food items and Drug Administration or the United States Patent and Trademark Business. Any of the foregoing threats could materially and adversely impact AskBio’s business enterprise and success of functions. You should not area undue reliance on the ahead-wanting statements contained in this press launch. AskBio does not undertake any obligation to publicly update its ahead-looking statements based on functions or circumstances after the day hereof. 

Check out original content material to download multimedia:https://www.prnewswire.com/news-releases/askbio-ceo-and-co-founder-sheila-mikhail-receives-2022-entrepreneurial-award-from-college-of-chicago-booth-school-of-business-301560981.html

Resource AskBio